Concepedia

Interim Analysis of Low Dose ENV515 Travoprost XR with 11 Month Duration Followed by Dose Escalation and 28 Day Efficacy Evaluation of High Dose ENV515

Steven L. Mansberger, Jinny Conley, Rozemarijn S Verhoeven, Kristin Blackwell, Michael Depenbusch, Tracey Knox, Thomas R. Walters, Iqbal Ahmad, Benjamin R. Yerxa, Tomáš Navrátil

Investigative Ophthalmology & Visual Science · 2017 · 12 citations · 0 references

Open access

Concepts

PharmacyPharmacologyPharmacotherapyPharmacovigilanceDose EscalationTreatment DurationDose Escalation EvaluationDose Escalation TherapyEfficacy Data EvaluationInterim Analysis